Incidence of premature battery depletion in subcutaneous cardioverter-defibrillator patients: insights from a multicenter registry.
Advisory
Implantable cardioverter-defibrillator
Longevity
Premature battery depletion
Subcutaneous ICD
Journal
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966
Informations de publication
Date de publication:
18 Jan 2023
18 Jan 2023
Historique:
received:
15
11
2022
accepted:
10
01
2023
entrez:
18
1
2023
pubmed:
19
1
2023
medline:
19
1
2023
Statut:
aheadofprint
Résumé
The subcutaneous ICD established its role in the prevention of sudden cardiac death in recent years. The occurrence of premature battery depletion in a large subset of potentially affected devices has been a cause of concern. The incidence of premature battery depletion has not been studied systematically beyond manufacturer-reported data. Retrospective data and the most recent follow-up data on S-ICD devices from fourteen centers in Europe, the US, and Canada was studied. The incidence of generator removal or failure was reported to investigate the incidence of premature S-ICD battery depletion, defined as battery failure within 60 months or less. Data from 1054 devices was analyzed. Premature battery depletion occurred in 3.5% of potentially affected devices over an observation period of 49 months. The incidence of premature battery depletion of S-ICD potentially affected by a battery advisory was around 3.5% after 4 years in this study. Premature depletion occurred exclusively in devices under advisory. This is in line with the most recently published reports from the manufacturer. ClinicalTrials.gov Identifier: NCT04767516 .
Sections du résumé
BACKGROUND
BACKGROUND
The subcutaneous ICD established its role in the prevention of sudden cardiac death in recent years. The occurrence of premature battery depletion in a large subset of potentially affected devices has been a cause of concern. The incidence of premature battery depletion has not been studied systematically beyond manufacturer-reported data.
METHODS
METHODS
Retrospective data and the most recent follow-up data on S-ICD devices from fourteen centers in Europe, the US, and Canada was studied. The incidence of generator removal or failure was reported to investigate the incidence of premature S-ICD battery depletion, defined as battery failure within 60 months or less.
RESULTS
RESULTS
Data from 1054 devices was analyzed. Premature battery depletion occurred in 3.5% of potentially affected devices over an observation period of 49 months.
CONCLUSIONS
CONCLUSIONS
The incidence of premature battery depletion of S-ICD potentially affected by a battery advisory was around 3.5% after 4 years in this study. Premature depletion occurred exclusively in devices under advisory. This is in line with the most recently published reports from the manufacturer.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov Identifier: NCT04767516 .
Identifiants
pubmed: 36652082
doi: 10.1007/s10840-023-01468-1
pii: 10.1007/s10840-023-01468-1
doi:
Banques de données
ClinicalTrials.gov
['NCT04767516']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, et al. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;2022(43):3997–4126.
doi: 10.1093/eurheartj/ehac262
Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, et al. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med. 2010;363:36–44.
doi: 10.1056/NEJMoa0909545
Gold MR, Lambiase PD, El-Chami MF, Knops RE, Aasbo JD, Bongiorni MG, Russo AM, Deharo JC, Burke MC, Dinerman J, Barr CS, Shaik N, Carter N, Stoltz T, Stein KM, Brisben AJ, Boersma LVA, Untouched I. Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED). Trial Circulation. 2021;143:7–17.
doi: 10.1161/CIRCULATIONAHA.120.048728
Knops RE, Olde Nordkamp LRA, Delnoy PHM, Boersma LVA, Kuschyk J, El-Chami MF, Bonnemeier H, Behr ER, Brouwer TF, Kääb S, Mittal S, Quast ABE, Smeding L, van der Stuijt W, de Weger A, de Wilde KC, Bijsterveld NR, Richter S, Brouwer MA, et al. Subcutaneous or transvenous defibrillator therapy. N Engl J Med. 2020;383:526–36.
doi: 10.1056/NEJMoa1915932
Hauser RG, Casey SA, Gitter CB, Tang CY, Abdelhadi RH, Gornick CC, Stanberry L, Sengupta JD. Reliability and longevity of implantable defibrillators. J Interv Card Electrophysiol. 2021;62(3):507–18.
doi: 10.1007/s10840-020-00920-w
Schwarzwald SN, Kersten DJ, Shaikh ZA, Needelman BS, Feldman AM, Germano J, Islam S, Cohen TJ. Mechanisms of lead failure by recall status and manufacturer: results from the pacemaker and implantable defibrillator leads survival study (“PAIDLESS”). J Invasive Cardiol. 2018;30:147–51.
Hauser RG, Hayes DL, Epstein AE, Cannom DS, Vlay SC, Song SL, Tyers GF. Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators. Heart Rhythm. 2006;3:640–4.
doi: 10.1016/j.hrthm.2006.02.011
Pokorney SD, Greenfield RA, Atwater BD, Daubert JP, Piccini JP. Novel mechanism of premature battery failure due to lithium cluster formation in implantable cardioverter-defibrillators. Heart Rhythm. 2014;11:2190–5.
doi: 10.1016/j.hrthm.2014.07.038
Montgomery JA, Sensing JY, Saunders SD, Clair WK, Abraham RL, Kanagasundram AN, Ellis CR, Crossley GH, Shoemaker MB, Saavedra P. Premature battery depletion due to compromised low-voltage capacitor in a family of defibrillators. Pacing and Clinical Electrophysiology. 2019;42:965–9.
doi: 10.1111/pace.13713
Ip JE. Premature battery depletion of EMBLEM subcutaneous implantable cardioverter-defibrillators. J Cardiovasc Electrophysiol. 2021;32:565–7.
doi: 10.1111/jce.14935
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81.
doi: 10.1016/j.jbi.2008.08.010
Boston Scientific. Important Medical Device Advisory Update. 2022. https://www.bostonscientific.com/content/dam/bostonscientific/quality/documents/Recent%20Product%20Advisories/2022Feb_BSC_EMBLEMHydPBD_PhysLtr_Final.pdf
Quast ABE, van Dijk VF, Yap SC, Maass AH, Boersma LVA, Theuns DA, Knops RE. Six-year follow-up of the initial Dutch subcutaneous implantable cardioverter-defibrillator cohort: long-term complications, replacements, and battery longevity. J Cardiovasc Electrophysiol. 2018;29:1010–6.
doi: 10.1111/jce.13498
Bettin M, Rath B, Ellermann C, Leitz P, Reinke F, Köbe J, Eckardt L, Frommeyer G. Follow-up of the first patients with a totally subcutaneous ICD in Germany from implantation till battery depletion. Clin Res Cardiol. 2019;108:16–21.
doi: 10.1007/s00392-018-1296-1
Gasperetti A, Schiavone M, Ziacchi M, Vogler J, Breitenstein A, Laredo M, Palmisano P, Ricciardi D, Mitacchione G, Compagnucci P, Bisignani A, Angeletti A, Casella M, Picarelli F, Fink T, Kaiser L, Hakmi S, Calò L, Pignalberi C, et al. Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience. Heart Rhythm. 2021;21(01866):S1547–5271.
Boston Scientific. Important Medical Device Advisory. 2020. https://www.bostonscientific.com/content/dam/bostonscientific/quality/dlt/reg-code-228/2020Dec_BSC_EmblemPBD_PhysLtr_US_Final.pdf
Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil P, Scholten M, Hood M, Kuschyk J, Jones P, Duffy E, Husby M, Stein K, Lambiase PD, Group EFFORTLESSI. Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: The EFFORTLESS Study. J Am Coll Cardiol. 2017;70:830–41.
doi: 10.1016/j.jacc.2017.06.040
Pothineni NVK, Cherian T, Patel N, Smietana J, Frankel DS, Deo R, Epstein AE, Marchlinski FE, Schaller RD. Subcutaneous implantable cardioverter-defibrillator explantation—a single tertiary center experience. J Innov Card Rhythm Manag. 2022;13:4947–53.
doi: 10.19102/icrm.2022.130407